ACVR1
ACVR1 is a human gene that encodes for the protein Activin A receptor type 1. This protein is a member of the protein kinase superfamily and the TGFB receptor subfamily. The encoded protein is a transmembrane serine/threonine kinase that is found in various tissues and cell types. It plays a crucial role in bone growth and development, and mutations in this gene are associated with the rare genetic disorder Fibrodysplasia Ossificans Progressiva (FOP).
Structure
The ACVR1 gene is located on the long (q) arm of chromosome 2 at position 24. The gene spans approximately 58,000 base pairs and consists of 11 exons. The encoded protein is a type I receptor with a molecular weight of approximately 53 kDa. It contains a glycosylation site, a transmembrane domain, a GS domain, and a serine/threonine kinase domain.
Function
ACVR1 is a receptor for members of the transforming growth factor-beta (TGF-beta) family, such as activin and bone morphogenetic protein (BMP). Upon ligand binding, ACVR1 forms a complex with a type II receptor, which phosphorylates and activates the type I receptor. The activated receptor then phosphorylates and activates SMAD proteins, which regulate gene expression and control a variety of cellular processes, including cell proliferation, differentiation, and death.
Clinical Significance
Mutations in the ACVR1 gene cause Fibrodysplasia Ossificans Progressiva (FOP), a rare and disabling genetic condition characterized by progressive ossification of soft tissues, leading to the formation of extra-skeletal bone. Most cases of FOP are caused by a specific mutation in ACVR1 (R206H) that leads to increased BMP signaling and enhanced osteogenic differentiation.
Research
Research into ACVR1 and its role in FOP has led to the development of potential therapeutic strategies, including the use of retinoic acid receptor gamma (RARγ) agonists and ALK2 kinase inhibitors. These treatments aim to reduce the abnormal bone formation associated with FOP by inhibiting the overactive BMP signaling pathway.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD